Puma Biotechnology Inc (PBYI) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Puma Biotechnology (PBYI) Q1 2026: Dose-Escalation Drives 25% New Rx Surge, Biomarker Focus Sharpens Pipeline
May 08, 2026
-
Puma Biotechnology (PBYI) Q3 2025: U.S. Nerlynx Sales Rise 6% as R&D Spend Accelerates
November 07, 2025
-
Puma Biotechnology (PBYI) Q2 2025: Neuralink Sales Up 12%, R&D Investment Signals Pipeline Acceleration
August 08, 2025